Applied Nutrition Plc/£APN
07:00
09:10
11:15
13:25
15:30
1D1W1MYTD1Y5YMAX
About Applied Nutrition Plc
Ticker
£APN
Sector
Primary listing
LSE
Employees
195
Headquarters
Website
APN Metrics
BasicAdvanced
£441M
0.59
£3.07
-
-
Price and volume
Market cap
£441M
52-week high
£1.80
52-week low
£1.04
Average daily volume
229K
Financial strength
Current ratio
4.37
Quick ratio
2.521
Long term debt to equity
3.325
Total debt to equity
4.038
Dividend payout ratio (TTM)
95.82%
Profitability
EBITDA (TTM)
19.956
Gross margin (TTM)
46.28%
Net profit margin (TTM)
17.36%
Operating margin (TTM)
21.81%
Effective tax rate (TTM)
24.07%
Revenue per employee (TTM)
£450,000
Management effectiveness
Valuation
Price to earnings (TTM)
0.586
Price to revenue (TTM)
0.102
Price to book
10.48
Price to tangible book (TTM)
10.5
Price to free cash flow (TTM)
1.632
Free cash flow yield (TTM)
61.26%
Free cash flow per share (TTM)
1.102
Growth
What the Analysts think about APN
Analyst ratings (Buy, Hold, Sell) for Applied Nutrition Plc stock.
Bulls say / Bears say
FY25 trading update delivered 24% revenue growth to £107 million and a 19% rise in adjusted EBITDA, with net cash of ~£18.5 million, and management raised FY26 revenue guidance above consensus of £112.4 million (Investing.com)
Strategic customer expansion includes a joint business plan with Holland & Barrett—set to triple revenue contribution by FY26—and new listings with GNC Corporate, Hy-vee and H-E-B in over 1,000 U.S. stores, expected to add $3 million annualized in H2 FY25 (Investing.com)
Shares jumped 8.5% to 142.5 pence on strong full-year results, valuing the company at ~£328 million and reflecting robust investor confidence since its 2024 IPO (The Times)
Pretax profit for H1 FY25 fell 27% to £11.8 million as administrative costs surged 61%, squeezing margins and causing shares to drop 5.6% on April 7, 2025 (Financial News)
Heavy reliance on CEO-founder Thomas Ryder, who holds ~34% of the equity, and on a single Liverpool manufacturing facility raises key man and operational concentration risks that could disrupt growth if leadership or capacity issues arise (The Times)
The international segment declined in H1 FY25 due to £5.5 million of Middle East orders being pulled into the prior year, highlighting vulnerability to timing shifts in large customer orders (Applied Nutrition PLC)
Data summarised monthly by Lightyear AI. Last updated on 7 Oct 2025.
APN Financial Performance
Revenues and expenses
APN Earnings Performance
Company profitability
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Applied Nutrition Plc stock?
Applied Nutrition Plc (APN) has a market cap of £441M as of October 10, 2025.
What is the P/E ratio for Applied Nutrition Plc stock?
The price to earnings (P/E) ratio for Applied Nutrition Plc (APN) stock is 0.59 as of October 10, 2025.
Does Applied Nutrition Plc stock pay dividends?
No, Applied Nutrition Plc (APN) stock does not pay dividends to its shareholders as of October 10, 2025.
When is the next Applied Nutrition Plc dividend payment date?
Applied Nutrition Plc (APN) stock does not pay dividends to its shareholders.
What is the beta indicator for Applied Nutrition Plc?
Applied Nutrition Plc (APN) does not currently have a Beta indicator.